CEVI — CellaVision AB Income Statement
0.000.00%
Last trade - 00:00
- SEK5.28bn
- SEK5.23bn
- SEK677.29m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 462 | 471 | 566 | 639 | 677 |
Cost of Revenue | |||||
Gross Profit | 337 | 313 | 392 | 438 | 463 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 335 | 361 | 403 | 481 | 510 |
Operating Profit | 127 | 110 | 163 | 158 | 167 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 129 | 112 | 158 | 148 | 164 |
Provision for Income Taxes | |||||
Net Income After Taxes | 99.2 | 89.5 | 125 | 118 | 130 |
Net Income Before Extraordinary Items | |||||
Net Income | 99.2 | 89.5 | 125 | 118 | 130 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 99.2 | 89.5 | 125 | 118 | 130 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.16 | 3.87 | 5.25 | 5.07 | 5.46 |
Dividends per Share |